NCT04088994 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Bressi B
Modulating the motor system by action observation in right hemiplegic cerebral palsy: an fMRI study. Nov. 2016, BSc Thesis in Physical Therapy. University of Modena and Reggio Emilia, Italy.
Errante A, Di Cesare G, Pinardi C, Fasano F, Sghedoni S, Costi S, Ferrari A, Fogassi L
Mirror Neuron System Activation in Children With Unilateral Cerebral Palsy During Observation of Actions Performed by a Pathological Model. Neurorehabil Neural Repair.

Rehabilitation of Hemiplegic Cerebral Palsy Children: Role of Motor Activity and Action Observation Therapy in the Recovery of the Affected Upper Limb

Details for clinical trial NCT04088994

Clinical trial NCT04088994 - References